TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. DIABETES DRUG MARKET, BY DRUG CLASS (USD BILLION)
6.1. Insulin
6.2. Sulfonylureas
6.3. Biguanides
6.4. DPP-4 Inhibitors
6.5. GLP-1 Receptor Agonists
7. DIABETES DRUG MARKET, BY ADMINISTRATION ROUTE (USD BILLION)
7.1. Oral
7.2. Injectable
7.3. Inhalation
7.4. Transdermal
8. DIABETES DRUG MARKET, BY THERAPEUTIC USE (USD BILLION)
8.1. Type 1 Diabetes
8.2. Type 2 Diabetes
8.3. Gestational Diabetes
9. DIABETES DRUG MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
9.1. Retail Pharmacies
9.2. Hospital Pharmacies
9.3. Online Pharmacies
10. DIABETES DRUG MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Diabetes Drug Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Diabetes Drug Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Takeda
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Pfizer
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. AbbVie
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Novo Nordisk
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Eli Lilly
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Boehringer Ingelheim
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Johnson and Johnson
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Roche
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Novartis
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Lupin Pharmaceuticals
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Merck
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. AstraZeneca
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. GlaxoSmithKline
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Amgen
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Sanofi
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 3. NORTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 4. NORTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 5. NORTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 6. NORTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7. US DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 8. US DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 9. US DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 10. US DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 11. US DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12. CANADA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 13. CANADA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 14. CANADA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 15. CANADA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 16. CANADA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17. EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 18. EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 19. EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 20. EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 21. EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22. GERMANY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 23. GERMANY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 24. GERMANY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 25. GERMANY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 26. GERMANY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27. UK DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 28. UK DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 29. UK DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 30. UK DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 31. UK DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32. FRANCE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 33. FRANCE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 34. FRANCE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 35. FRANCE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 36. FRANCE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37. RUSSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 38. RUSSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 39. RUSSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 40. RUSSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 41. RUSSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42. ITALY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 43. ITALY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 44. ITALY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 45. ITALY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 46. ITALY DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47. SPAIN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 48. SPAIN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 49. SPAIN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 50. SPAIN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 51. SPAIN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52. REST OF EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 53. REST OF EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 54. REST OF EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 55. REST OF EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 56. REST OF EUROPE DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57. APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 58. APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 59. APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 60. APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 61. APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62. CHINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 63. CHINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 64. CHINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 65. CHINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 66. CHINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67. INDIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 68. INDIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 69. INDIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 70. INDIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 71. INDIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72. JAPAN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 73. JAPAN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 74. JAPAN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 75. JAPAN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 76. JAPAN DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 77. SOUTH KOREA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 78. SOUTH KOREA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 79. SOUTH KOREA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 80. SOUTH KOREA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 81. SOUTH KOREA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 82. MALAYSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 83. MALAYSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 84. MALAYSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 85. MALAYSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 86. MALAYSIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 87. THAILAND DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 88. THAILAND DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 89. THAILAND DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 90. THAILAND DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 91. THAILAND DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 92. INDONESIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 93. INDONESIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 94. INDONESIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 95. INDONESIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 96. INDONESIA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 97. REST OF APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 98. REST OF APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 99. REST OF APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 100. REST OF APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 101. REST OF APAC DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 102. SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 103. SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 104. SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 105. SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 106. SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 107. BRAZIL DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 108. BRAZIL DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 109. BRAZIL DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 110. BRAZIL DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 111. BRAZIL DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 112. MEXICO DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 113. MEXICO DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 114. MEXICO DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 115. MEXICO DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 116. MEXICO DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 117. ARGENTINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 118. ARGENTINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 119. ARGENTINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 120. ARGENTINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 121. ARGENTINA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 127. MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 128. MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 129. MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 130. MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 131. MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 132. GCC COUNTRIES DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 133. GCC COUNTRIES DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 134. GCC COUNTRIES DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 135. GCC COUNTRIES DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 136. GCC COUNTRIES DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 137. SOUTH AFRICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 138. SOUTH AFRICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 139. SOUTH AFRICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 140. SOUTH AFRICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 141. SOUTH AFRICA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 142. REST OF MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2035 (USD BILLIONS)
TABLE 143. REST OF MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD BILLIONS)
TABLE 144. REST OF MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC USE, 2019-2035 (USD BILLIONS)
TABLE 145. REST OF MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 146. REST OF MEA DIABETES DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA DIABETES DRUG MARKET ANALYSIS
FIGURE 3. US DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 4. US DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 5. US DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 6. US DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 7. US DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 9. CANADA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 10. CANADA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 11. CANADA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 12. CANADA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE DIABETES DRUG MARKET ANALYSIS
FIGURE 14. GERMANY DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 15. GERMANY DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 16. GERMANY DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 17. GERMANY DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 18. GERMANY DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 20. UK DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 21. UK DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 22. UK DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 23. UK DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 25. FRANCE DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 26. FRANCE DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 27. FRANCE DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 28. FRANCE DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 30. RUSSIA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 31. RUSSIA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 32. RUSSIA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 33. RUSSIA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 35. ITALY DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 36. ITALY DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 37. ITALY DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 38. ITALY DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 40. SPAIN DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 41. SPAIN DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 42. SPAIN DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 43. SPAIN DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 45. REST OF EUROPE DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 46. REST OF EUROPE DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 47. REST OF EUROPE DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 48. REST OF EUROPE DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC DIABETES DRUG MARKET ANALYSIS
FIGURE 50. CHINA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 51. CHINA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 52. CHINA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 53. CHINA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 54. CHINA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 56. INDIA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 57. INDIA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 58. INDIA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 59. INDIA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 61. JAPAN DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 62. JAPAN DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 63. JAPAN DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 64. JAPAN DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 66. SOUTH KOREA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 67. SOUTH KOREA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 68. SOUTH KOREA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 69. SOUTH KOREA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 71. MALAYSIA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 72. MALAYSIA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 73. MALAYSIA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 74. MALAYSIA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 76. THAILAND DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 77. THAILAND DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 78. THAILAND DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 79. THAILAND DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 81. INDONESIA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 82. INDONESIA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 83. INDONESIA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 84. INDONESIA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 86. REST OF APAC DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 87. REST OF APAC DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 88. REST OF APAC DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 89. REST OF APAC DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA DIABETES DRUG MARKET ANALYSIS
FIGURE 91. BRAZIL DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 92. BRAZIL DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 93. BRAZIL DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 94. BRAZIL DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 95. BRAZIL DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 97. MEXICO DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 98. MEXICO DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 99. MEXICO DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 100. MEXICO DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 102. ARGENTINA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 103. ARGENTINA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 104. ARGENTINA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 105. ARGENTINA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 107. REST OF SOUTH AMERICA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 108. REST OF SOUTH AMERICA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 109. REST OF SOUTH AMERICA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 110. REST OF SOUTH AMERICA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA DIABETES DRUG MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 113. GCC COUNTRIES DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 114. GCC COUNTRIES DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 115. GCC COUNTRIES DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 116. GCC COUNTRIES DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 118. SOUTH AFRICA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 119. SOUTH AFRICA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 120. SOUTH AFRICA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 121. SOUTH AFRICA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA DIABETES DRUG MARKET ANALYSIS BY DRUG CLASS
FIGURE 123. REST OF MEA DIABETES DRUG MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 124. REST OF MEA DIABETES DRUG MARKET ANALYSIS BY THERAPEUTIC USE
FIGURE 125. REST OF MEA DIABETES DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 126. REST OF MEA DIABETES DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF DIABETES DRUG MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF DIABETES DRUG MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: DIABETES DRUG MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: DIABETES DRUG MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: DIABETES DRUG MARKET
FIGURE 133. DIABETES DRUG MARKET, BY DRUG CLASS, 2025 (% SHARE)
FIGURE 134. DIABETES DRUG MARKET, BY DRUG CLASS, 2019 TO 2035 (USD Billions)
FIGURE 135. DIABETES DRUG MARKET, BY ADMINISTRATION ROUTE, 2025 (% SHARE)
FIGURE 136. DIABETES DRUG MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions)
FIGURE 137. DIABETES DRUG MARKET, BY THERAPEUTIC USE, 2025 (% SHARE)
FIGURE 138. DIABETES DRUG MARKET, BY THERAPEUTIC USE, 2019 TO 2035 (USD Billions)
FIGURE 139. DIABETES DRUG MARKET, BY DISTRIBUTION CHANNEL, 2025 (% SHARE)
FIGURE 140. DIABETES DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions)
FIGURE 141. DIABETES DRUG MARKET, BY REGIONAL, 2025 (% SHARE)
FIGURE 142. DIABETES DRUG MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
